Numeric Investors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Numeric Investors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$296K	Buy	+2,200	New	+$305K	﹤0.01%	977
2016 Q4	–	Sell	-9,800	Closed	-$1.19M	–	1111
2016 Q3	$1.19M	Sell	9,800 -14,500	-60%	-$1.95M	0.01%	575
2016 Q2	$3.43M	Buy	+24,300	New	+$3.58M	0.03%	354
2015 Q1	–	Sell	-4,800	Closed	-$786K	–	963
2014 Q4	$786K	Buy	+4,800	New	+$797K	0.01%	496
2014 Q2	–	Sell	-3,080	Closed	-$427K	–	839
2014 Q1	$427K	Sell	3,080 -420	-12%	-$63.2K	0.01%	620
2013 Q4	$443K	Buy	+3,500	New	+$362K	0.01%	630
2013 Q3	–	Sell	-18,300	Closed	-$1.26M	–	808
2013 Q2	$1.26M	Buy	+18,300	New	+$1.12M	0.03%	371

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SIG

Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Numeric Investors's JAZZ Position: Q4 2017 in Review

Numeric Investors opened a new position in Jazz Pharmaceuticals (JAZZ) in Q4 2017: 2,200 shares worth $296K. The stake represents ﹤0.01% of the portfolio and ranks #977 among its holdings. This is a return to the name: Numeric Investors previously reported a position in JAZZ as recently as Q3 2016.

Numeric Investors first reported a position in JAZZ in Q2 2013 and has held it in 7 quarters since. The position peaked at $3.43M in Q2 2016. 323 funds tracked by Wall St. Rank hold JAZZ as of Q4 2017.

Numeric Investors held 2,200 shares of Jazz Pharmaceuticals worth $296K as of Q4 2017.
Jazz Pharmaceuticals was a new Numeric Investors position in Q4 2017.
Jazz Pharmaceuticals made up ﹤0.01% of Numeric Investors's portfolio in Q4 2017, its #977 holding.
Numeric Investors first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 7 quarters since.
Numeric Investors's Jazz Pharmaceuticals position peaked at $3.43M in Q2 2016.
323 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.